| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income | 10,470 | 7,629 | 18,598 | 17,764 |
| Loss before (provision for) benefit from income taxes | -162,973 | -110,788 | -120,949 | -213,540 |
| (provision for) benefit from income taxes | 168 | 170 | 16 | 177 |
| Net loss | - | - | - | -213,717 |
| Net loss | -163,141 | -110,958 | -120,965 | -213,717 |
| Net loss per share, basic (in usd per share) | -1.17 | -0.8 | -0.88 | -1.56 |
| Net loss per share, diluted (in usd per share) | -1.17 | -0.8 | -0.88 | -1.56 |
| Weighted-average shares outstanding, basic (in shares) | 138,930,173 | 138,447,469 | 137,468,900 | 136,653,753 |
| Weighted-average shares outstanding, diluted (in shares) | 138,930,173 | 138,447,469 | 137,468,900 | 136,653,753 |
Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. (VIR)